Xanthine derivatives as selective HM74A agonists

Details for Australian Patent Application No. 2006278215 (hide)

Owner SmithKline Beecham Corporation

Inventors Pinto, Ivan Leo; Hatley, Richard Jonathan Daniel; Mason, Andrew Mcmurtrie

Agent Davies Collison Cave

Pub. Number AU-A-2006278215

PCT Pub. Number WO2007/017261

Priority 0614569.2 21.07.06 GB; 0607736.6 19.04.06 GB; 0516464.5 10.08.05 GB

Filing date 8 August 2006

Wipo publication date 15 February 2007

International Classifications

C07D 473/06 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/017261 Priority application(s): WO2007/017261

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278216-Xanthine derivatives as selective HM74A agonists

2006278210-Method for controlling phytopathogenic organisms